Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Larimar Therapeutics, Inc. | d857439dex231.htm |
| EX-5.1 - EX-5.1 - Larimar Therapeutics, Inc. | d857439dex51.htm |
As filed with the Securities and Exchange Commission on January 22, 2015
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ZAFGEN, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 2834 | 20-3857670 | ||
| (State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification No.) |
Zafgen, Inc.
175 Portland Street, 4th Floor
Boston, Massachusetts 02114
(617) 622-4003
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Thomas E. Hughes, Ph.D.
Chief Executive Officer
Zafgen, Inc.
175 Portland Street, 4th Floor
Boston, Massachusetts 02114
(617) 622-4003
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
| Mitchell S. Bloom, Esq. Michael J. Minahan, Esq. Laurie A. Burlingame, Esq. Goodwin Procter LLP Exchange Place Boston, Massachusetts 02109 (617) 570-1000 |
Thomas E. Hughes, Ph.D. Chief Executive Officer Zafgen, Inc. 175 Portland Street, 4th Floor Boston, Massachusetts 02114 (617) 622-4003 |
Patrick O’Brien, Esq. Ropes & Gray LLP Prudential Tower Boston, Massachusetts 02199 (617) 951-7000 |
Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective.
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ¨
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. x 333-201439
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ¨ | Accelerated filer ¨ | |
| Non-accelerated filer x | Smaller reporting company ¨ | |
| (Do not check if a smaller reporting company) | ||
CALCULATION OF REGISTRATION FEE
| Title of securities to be registered | Amount to be registered(1) |
Proposed maximum offering price per share(2) |
Proposed maximum aggregate offering price |
Amount of registration fee(3) | ||||
| Common stock, $0.001 par value per share |
539,806 | $35.00 | $18,893,210 | $2,196 |
| (1) | Represents only the additional number of shares being registered and includes shares of common stock issuable upon exercise of the underwriters’ option to purchase additional shares. Does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1 (File No. 333-201439). |
| (2) | Based on the public offering price of $35.00 per share. |
| (3) | The registration fee is calculated in accordance with Rule 457(a) under the Securities Act of 1933, as amended. The registrant previously registered securities at an aggregate offering price not to exceed $119,083,790 on a Registration Statement on Form S-1 (File No. 333-201439), which was declared effective by the Securities and Exchange Commission on January 22, 2015. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $18,893,210 is hereby registered, which includes shares issuable upon the exercise of the underwriters’ option to purchase additional shares. |
This registration statement shall become effective upon filing with the Commission in accordance with Rule 462(b) of the Securities Act of 1933, as amended.
EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
This Registration Statement is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the “Securities Act”). The contents of Amendment No. 1 to the Registration Statement on Form S-1 (File No. 333-201439) filed by Zafgen, Inc. with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act, which was declared effective by the Commission on January 22, 2015, are incorporated by reference into this Registration Statement.
The required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Boston, Commonwealth of Massachusetts, this 22nd day of January, 2015.
| ZAFGEN, INC. | ||
| By: | /s/ Thomas E. Hughes | |
| Thomas E. Hughes, Ph.D. Chief Executive Officer | ||
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated below.
| Signature |
Title |
Date | ||
| /s/ Thomas E. Hughes THOMAS E. HUGHES, PH.D. |
Chief Executive Officer and Director (Principal Executive Officer) |
January 22, 2015 | ||
| /s/ Patricia L. Allen PATRICIA L. ALLEN |
Chief Financial Officer (Principal Financial and Accounting Officer) |
January 22, 2015 | ||
| * PETER BARRETT, PH.D. |
Chairman of the Board and Director |
January 22, 2015 | ||
| * BRUCE BOOTH, PH.D. |
Director |
January 22, 2015 | ||
| * AVI GOLDBERG |
Director |
January 22, 2015 | ||
| * FRANCES K. HELLER |
Director |
January 22, 2015 | ||
| * JOHN L. LAMATTINA, PH.D. |
Director |
January 22, 2015 | ||
| * KEVIN P. STARR |
Director |
January 22, 2015 | ||
| * FRANK E. THOMAS |
Director |
January 22, 2015 | ||
| * Pursuant to Power of Attorney | ||
| By: | /s/ Thomas E. Hughes | |
| Thomas E. Hughes, Ph.D. Attorney-in-Fact | ||
II-1
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 5.1 | Opinion of Goodwin Procter LLP | |
| 23.1 | Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm | |
| 23.2 | Consent of Goodwin Procter LLP (included in Exhibit 5.1) | |
| 24.1* | Power of Attorney | |
| * | Previously filed with the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-201439), filed with the SEC on January 16, 2015 and incorporated by reference herein |
II-2